Faculty profile

David Gladstone

ResearcherMedicine/NeurologyUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.

David Gladstone

Researcher

Medicine/Neurology

Health Sciences

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
5 publications in the last five years, latest in 2026.
Principal investigator on 2 research grants (2 CIHR), most recently in 2025.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

1,156

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Anticoagulation Cardiac Embolism Cardiology Echocardiography Left Ventricular Dysfunction Prevention Stroke

Latest papers

Prevalence, burden and manifestation of atrial fibrillation: a large-scale analysis of cardiac patch monitors.
Heart · 2026
Markers of left atrial cardiopathy and cognitive function trajectories in adults aged ≥ 45 years without atrial fibrillation: a population-based study.
BMC neurology · 2026
Apixaban versus aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischaemic attack: subgroup analysis of the ARTESiA randomised controlled trial
Lancet Neurology · 2025

All 15 publications

Latest funding

EAST-STROKE: A Randomized Controlled Trial of Rhythm Control vs. Standard of Care for Atrial Fibrillation in Acute Ischemic Stroke
CIHR · 2025 · Co-investigator
$971,550
The RESOLVE Trial: Reducing Embolic Stroke with Optimal Antithrombotic Therapy in Left Ventricular Injury and Low Ejection Fraction
CIHR · 2025 · Nominated PI
$673,159
Medical Treatment With or Without Transcatheter Patent Foramen Ovale Closure for Older Patients with Cryptogenic Stroke and Patent Foramen Ovale: A Randomized Trial Research Proposal
CIHR · 2023 · Co-investigator
$952,425

All 14 grants and awards

15 publications.

Prevalence, burden and manifestation of atrial fibrillation: a large-scale analysis of cardiac patch monitors.

Sigfstead S, Newman D, Nault I, Gladstone D, Tang A, Macle L, Healey JS, Andrade JG, Kaba RA, Cheung CC

Heart2026

DOI: 10.1136/heartjnl-2026-328587

Markers of left atrial cardiopathy and cognitive function trajectories in adults aged ≥ 45 years without atrial fibrillation: a population-based study.

Li Z, Marion D, Blair J, Soliman EZ, Gladstone D, Kamel H, Birnie D, Manuel D, Unverzagt FW, Howard V, Edwards JD

BMC neurology2026

DOI: 10.1186/s12883-026-04856-y PMID: 42015111

Apixaban versus aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischaemic attack: subgroup analysis of the ARTESiA randomised controlled trial

Shoamanesh A, Field TS, Coutts SB, Sharma M, Gladstone D, Hart RG, Boriani G, Wright DJ, Sticherling C, Birnie DH

Lancet Neurology202553 citations

DOI: 10.1016/s1474-4422(24)00475-7

Association Between Markers of Atrial Cardiopathy and Cognitive Impairment Risk Among Adults with No Suggestive History of Atrial Fibrillation.

Li Z, Marion D, Blair J, Soliman EZ, Gladstone D, Kamel H, Birnie D, Manuel D, Unverzagt FW, Howard VJ, Edwards JD

CJC open2025

DOI: 10.1016/j.cjco.2025.07.010 PMID: 41542129

Clinical Features, Non-Contrast CT Radiomic and Radiological Signs in Models for the Prediction of Hematoma Expansion in Intracerebral Hemorrhage.

Chen ZF, Zhang L, Carrington AM, Thornhill R, Miguel O, Auriat AM, Omid-Fard N, Hiremath S, Tshemeister Abitbul V, Dowlatshahi D, Demchuk A, Gladstone D, Morotti A, Casetta I, Fainardi E, Huynh T, Elkabouli M, Talbot Z, Melkus G, Aviv RI

Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes2023

DOI: 10.1177/08465371231168383 PMID: 37070854

Original and Modified Graeb Score Correlation With Intraventricular Hemorrhage and Clinical Outcome Prediction in Hyperacute Intracranial Hemorrhage.

Bisson DA, Flaherty ML, Shatil AS, Gladstone D, Dowlatshahi D, Carrozzella J, Zhang L, Hill MD, Demchuck A, Aviv RI, STOP-IT and SPOTLIGHT Investigators

Stroke2020

DOI: 10.1161/strokeaha.120.029040 PMID: 32390552

Reinitiation of Anticoagulation After Surgical Evacuation of Subdural Hematomas.

Nassiri F, Hachem LD, Wang JZ, Badhiwala JH, Zadeh G, Gladstone D, Scales DC, Pirouzmand F

World neurosurgery2020

DOI: 10.1016/j.wneu.2019.12.080 PMID: 31874290

2018 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation

Andrade JG, Verma A, Mitchell LB, Parkash R, Leblanc K, Atzema C, Healey JS, Bell A, Cairns J, Connolly S

Canadian Journal of Cardiology2018224 citations

DOI: 10.1016/j.cjca.2018.08.026

2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation

Macle L, Cairns J, Leblanc K, Tsang T, Skanes A, Cox JL, Healey JS, Bell A, Pilote L, Andrade JG

Canadian Journal of Cardiology2016256 citations

DOI: 10.1016/j.cjca.2016.07.591

High prevalence of modifiable stroke risk factors identified in a pharmacy-based screening programme

Sandhu RK, Dolovich L, Deif B, Barake W, Agarwal G, Grinvalds A, Lim T, Quinn FR, Gladstone D, Conen D

Open Heart201647 citationsOpen Access

DOI: 10.1136/openhrt-2016-000515 PMID: W2563498899

Something wrong or missing on this profile? Suggest a correction

David Gladstone

Research

Latest papers

Latest funding

Prevalence, burden and manifestation of atrial fibrillation: a large-scale analysis of cardiac patch monitors.

Markers of left atrial cardiopathy and cognitive function trajectories in adults aged&#x2009;&#x2265;&#x2009;45 years without atrial fibrillation: a population-based study.

Apixaban versus aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischaemic attack: subgroup analysis of the ARTESiA randomised controlled trial

Association Between Markers of Atrial Cardiopathy and Cognitive Impairment Risk Among Adults with No Suggestive History of Atrial Fibrillation.

Clinical Features, Non-Contrast CT Radiomic and Radiological Signs in Models for the Prediction of Hematoma Expansion in Intracerebral Hemorrhage.

Original and Modified Graeb Score Correlation With Intraventricular Hemorrhage and Clinical Outcome Prediction in Hyperacute Intracranial Hemorrhage.

Reinitiation of Anticoagulation After Surgical Evacuation of Subdural Hematomas.

2018 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation

2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation

High prevalence of modifiable stroke risk factors identified in a pharmacy-based screening programme

Frequent collaborators

Jeff Healey

Laurent Macle

Paul Dorian

Stanley Nattel

Mukul Sharma

Dar Dowlatshahi

Gustavo Saposnik

David Birnie

Ratika Parkash

Robert Hart

Teresa Tsang

Clare Atzema

Louise Pilote

Farshad Nassiri

FARHAD Pirouzmand

Gerd Melkus

Léna Rivard

Noah Ivers

Noah Ivers

David Conen

Demetrios Sahlas

Ashkan Shoamanesh

William McIntyre

Markers of left atrial cardiopathy and cognitive function trajectories in adults aged ≥ 45 years without atrial fibrillation: a population-based study.